An observational study in Delirium and Artificial Intelligence (AI), sponsored by Beijing Tiantan Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-08-22.
Sponsored by Beijing Tiantan Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Delirium with a site in China — 29 open to participants now, 30 under way, none of them phase 3. Delirium · China.
Among the 96 studies in Delirium with a site in China, this one is the 4th largest by planned enrollment of the 30 observational ones that give a count, is one of 8 that started in 2025, is one of 30 observational ones, reaches primary completion later than 10 of the 29 other live ones, and was the 87th registered.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →29 of the 96 studies in Delirium with a site in China are open now. Recruiting first, the newest first:
Shanghai Zhongshan Hospital · Sites in China
Ages 18+
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Sites in China
Ages 18–80
Chinese University of Hong Kong · Sites in China
Ages 18+
China National Center for Cardiovascular Diseases · Sites in China
Ages 18–80
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Sites in China
Ages 18–90
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 8 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,000 is above the median of 196 across 343 observational studies indexed under Delirium.
Median enrollment 262 across the 66 interventional studies, 249 across the 30 observational. Of the 42 that completed or were terminated, 5 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 96 have an industry lead sponsor. The 10 most frequent:
Beijing Tiantan Hospital is the lead sponsor of 494 studies on the registry; 298 are open to participants now.
Beijing Tiantan Hospital has 4 studies filed under Delirium — fewer than ten, so there is no comparison to draw.
8 of the studies in Delirium with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06007755Huazhong University of Science and TechnologyExploring of Serum Biomarkers of Delirium After Cardiovascular Surgery | 2026-12 |
| NCT04832568Huazhong University of Science and TechnologyPerioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery | 2026-12 |
| NCT04091724Huazhong University of Science and TechnologyPerioperative EEG-Monitoring and Emergence Delirium in Children | 2026-12 |
| NCT04789733The Cleveland ClinicThe GUARDIAN Pilot Trial | 2026-12-31 |
| NCT05525702Peking Union Medical College HospitalVR Interventions to Reduce the Prevalence of Delirium in ICU Patients | 2026-12-31 |
Add all 8 to your calendar (.ics) → With an account.
Among the 96 studies in Delirium with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This research project employs machine learning algorithms integrated with computer vision, image processing, and pattern recognition technologies to perform digital analysis of facial expression behaviors in neurocritical care patients with delirium. By constructing multidimensional high-level features of delirium, the investigators have established a classification model based on behavioral. The primary objective of this study is to address the critical challenge of achieving precise and efficient delirium diagnosis in neurologically critically ill patients through automated facial expression behavior recognition.
This study is a prospective cohort study approved by the Ethics Committee of Beijing Tiantan Hospital. It aims to support the accurate and efficient diagnosis of delirium in neurocritical patients through a facial expression recognition system. A mobile application was developed for this study, collaboratively designed by senior clinicians and engineers from the Institute of Computing Technology, Chinese Academy of Sciences. The application is based on a stimulus paradigm designed using CAM-ICU (Confusion Assessment Method for the Intensive Care Unit) questions to record dynamic facial videos of neurocritical patients following delirium evaluation based on the DSM-V criteria.
Patients were assessed for delirium and facial expression behavior data were collected twice daily during ICU admission, in two time slots: 8:00-10:00 AM and 8:00-10:00 PM, following the study's inclusion and exclusion criteria. A trained and experienced specialist used the gold standard DSM-V to diagnose delirium. Within five minutes after completing the assessment, dynamic facial behavior video data were collected to prepare images for subsequent model development.
Various image preprocessing and data augmentation techniques were employed to prepare the images for the VGG16 model. These techniques are standard for running convolutional neural network (CNN) models. Using the "preprocess_input"function from the Keras VGGFace module, the investigators standardized image color and size to ensure that each image met the expected input requirements for model training. For data augmentation, the investigators applied TensorFlow's "ImageDataGenerator" function to perform horizontal flipping, rotation, scaling, width and height shifting, and shearing. These augmentation techniques created a more diverse dataset, helping to prevent overfitting and improving the model's generalizability to new faces.
The investigators developed a binary classification model to identify delirium using a CNN with a pretrained backbone. The VGG16 model, based on deep learning, was adopted, leveraging transfer learning from VGGFace2, which possesses pre-existing facial feature recognition capabilities. Transfer learning allowed us to utilize prior knowledge to detect features more quickly, accurately, and with lower computational cost. The VGGFace2 model was employed for training.
Model performance was evaluated through internal validation at Beijing Tiantan Hospital and external validation at Guiyang Second People's Hospital, with metrics including accuracy, sensitivity, specificity, and F1 score. Additionally, to address the "black box" issue of machine learning, occlusion heatmap techniques were used to identify the most critical facial regions for delirium assessment, with the results visualized on a virtual face.
This model aims to support precise and efficient identification of delirium in neurocritical care units.
This study selects neurocritical patients as the population and collects facial expression data from both delirium and non-delirium patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
For neurocritical non-delirium patients, the investigators record facial expression videos, which are used during model development to compare with the facial expressions of delirium patients.
The investigators record facial expression videos of neurocritical delirium patients and perform frame sampling on the videos to analyze and extract the facial expression features specific to delirium. Based on this analysis, the investigators develop a model for delirium recognition in neurocritical patients.
Accuracy of the delirium prediction model
The accuracy of the delirium prediction model will be calculated as the proportion of correct predictions among total predictions.
Time frame: Through study completion, an average of 1 year
Sensitivity of the delirium prediction model
Sensitivity (true positive rate) will be assessed as the proportion of actual delirium cases correctly identified by the model.
Time frame: Through study completion, an average of 1 year
Specificity of the delirium prediction model
Specificity (true negative rate) will be calculated as the proportion of non-delirium cases correctly identified by the model.
Time frame: Through study completion, an average of 1 year
F1 Score of the delirium prediction model
The F1 score, the harmonic mean of precision and recall, will be used to evaluate the balance between sensitivity and specificity.
Time frame: Through study completion, an average of 1 year
AUC of the facial feature curve for delirium patients
The area under the curve (AUC) of the receiver operating characteristic (ROC) curve derived from facial features will be used to assess the discriminatory performance of the model.
Time frame: Through study completion, an average of 1 year
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — This study involves collecting facial information of patients, which pertains to their privacy. To protect participants' confidentiality, all data will be uniformly destroyed after the study is completed. The investigators will not share or disclose patients' information to other researchers.
Start is estimated for Aug 2025; primary completion for Dec 2025, 4 months later.
Of 177 non-industry observational studies under Delirium, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 37. This study's planned 4 months is below that.
Counting every sponsor, half of 179 studies reached it within 20 months; a quarter within 11 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.